ITGAE and cancer: In this study, the sourcing of biological samples from different patients with cancer will help to identify common immune markers of CD103+ T cells that can modulate protective antitumor immunity beyond the interaction between the TCR and a peptide in the major histocompatibility complex (pMHC).